Incretin-Based Therapy Reduces Post-Bariatric Alcohol Use Disorder Risk: JAMA Medha Baranwal26 Dec 2025 8:00 AM ISTUSA: Recent research suggests that incretin-based weight-loss therapies may offer important neurobehavioral benefits for patients who have undergone...
Sleep Disorders may Worsen Outcomes in Patients With Severe Asthma: Study Dr. Shravani Dali25 Dec 2025 8:45 PM ISTRegistry-based data indicate that comorbid sleep disorders are common in severe asthma and are associated with significantly worse clinical outcomes....
Valacyclovir Ineffective for Cognitive Outcomes in Early Alzheimer's Disease: JAMA Dr Riya Dave25 Dec 2025 8:30 PM ISTResearchers have found in a new study published in JAMA that valacyclovir showed no efficacy and was associated with cognitive worsening for the...
Chronic Skin Diseases Linked to Addictive Behaviors via Reduced Quality of Life: Study Medha Baranwal25 Dec 2025 8:15 PM ISTGermany: Higher Dermatology Life Quality Index (DLQI) scores were positively correlated with addictive behaviors, suggesting maladaptive coping...
Tinnitus, Not Hearing Loss, Drives Depression Risk in Older Adults: Study Finds Medha Baranwal24 Dec 2025 8:45 PM ISTUSA: A new study published in The Laryngoscope highlights that tinnitus, rather than hearing loss, may play a more significant role in depression...
Dose of psilocybin, dash of rabies point to treatment for depression, suggests research Dr. Kamal Kant Kohli24 Dec 2025 8:15 PM ISTAn international collaboration led by Cornell University researchers used a combination of psilocybin and the rabies virus to map how-and where-the...
Misinformation about Prenatal Use of Cannabis by Retailers Raises Safety Concerns: JAMA Medha Baranwal23 Dec 2025 9:00 PM ISTUSA: Cannabis use during pregnancy is linked to risks such as preeclampsia and low birthweight. In a secret shopper study of California cannabis...
Felbamate Shows Sustained Use and Safety in Pediatric Epilepsy: Study Dr Riya Dave23 Dec 2025 8:30 AM ISTAccording to new research more than half of children with refractory epilepsy treated with felbamate remain on therapy for at least one year without...
FDA Clears cranial electrotherapy stimulation device for Home-Based Treatment of Major Depressive Disorder Dr. Kamal Kant Kohli22 Dec 2025 8:45 PM ISTThe FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe major depressive...
Granules Pharma earns USFDA tentative nod for Attention Deficit Hyperactivity Disorder drug Ruchika Sharma22 Dec 2025 11:21 AM ISTHyderabad: Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has received tentative approval from the U.S. Food and Drug...
Specific Midlife Depression Symptoms Linked to Higher Dementia Risk: Lancet Medha Baranwal21 Dec 2025 8:45 PM ISTUK: A long-term UK cohort study has identified a distinct cluster of depressive symptoms in midlife that may signal a higher risk of developing...
Worsening Diabetes Complications Lower Quality of Life in Type 1 Diabetes, Suggests Study Medha Baranwal20 Dec 2025 9:30 AM ISTFrance: A study in Diabetes, Obesity and Metabolism found that adults with type 1 diabetes experienced a decline in health-related quality of life as...
